European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025
Jun 13 - Jun 16, 2025
- Title: Clinical Validation of a Novel Kinin Biomarker Assay for Characterization of Bradykinin-Mediated Pathologies in U.S. Subjects with Hereditary Angioedema
Presenter: Evangelia Pardali, Ph.D.
Format: Flash Talk (e-Poster), Abstract #000949, FT03
Date, Time: Friday, June 13, 13:15-14:45 BST (8:15-9:45 a.m. ET) - Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Results of the CHAPTER-1 Open-Label Extension Study
Presenter: Emel Aygören-Pürsün, M.D.
Format: Thematic Poster Session (e-Poster and Poster Session) Abstract #000070
Date, Time: Saturday, June 14, 12:00-13:00 BST (7:00-8:00 a.m. ET) - Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
Presenter: Henriette Farkas, M.D., Ph.D., D.Sc.
Format: Thematic Poster Session (e-Poster and Poster Session), Abstract #000069
Date, Time: Saturday, June 14, 12:00-13:00 BST (7:00-8:00 a.m. ET) - Title: Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema due to C1 Inhibitor Deficiency
Presenter: Andrea Zanichelli, M.D., Ph.D.
Format: Thematic Poster Session (e-Poster and Poster Session), Abstract #000331
Date, Time: Sunday, June 15, 12:45-13:45 BST (7:45-8:45 a.m. ET) - Title: Safety and Efficacy of Oral Deucrictibant for Treatment of Upper Airway and Laryngeal Hereditary Angioedema Attacks: Results from the RAPIDe-2 Extension Study
Presenter: Anna Valerieva, M.D., Ph.D.
Format: Flash Talk (e-Poster), Abstract #000076, FT16
Date, Time: Sunday, June 15, 14:00-15:30 BST (9:00-10:30 a.m. ET) - Title: CHAPTER-3 Phase 3 Trial Design: Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Extended-Release Tablet for Prophylaxis of Hereditary Angioedema Attacks
Presenter: William Lumry, M.D.
Format: Flash Talk (e-Poster), Abstract #000068, FT16
Date, Time: Sunday, June 15, 14:00-15:30 BST (9:00-10:30 a.m. ET) - Title: Long-Term Prophylactic Treatment with Oral Deucrictibant Improves Disease Control and Health-Related Quality of Life in Participants with Hereditary Angioedema in the CHAPTER-1 Open-Label Extension Study
Presenter: Markus Magerl, M.D.
Format: Flash Talk (e-Poster), Abstract #000075, FT16
Date, Time: Sunday, June 15, 14:00-15:30 BST (9:00-10:30 a.m. ET) - Title: Health-Related Quality of Life and Clinical Characteristics in People Living with Hereditary Angioedema Prescribed Long Term Prophylaxis Alone and On-Demand Treatment Alone
Presenter: Laurence Bouillet, M.D., Ph.D.
Format: Oral Presentation, Abstract #000044, OAS18
Date, Time: Sunday, June 15, 15:45-17:15 BST (10:45 a.m.-12:15 p.m. ET)